Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Estrogen Receptor ChIP-seq analysis of MCF7 cells treated with abemaciclib

ABSTRACT: Estrogen Receptor ChIP-seq analysis of MCF7 cells treated with abemaciclib

PROVIDER: PRJNA660449 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR12556668.fastq.gz	Fastqsanger.gz
	SRR12556669.fastq.gz	Fastqsanger.gz

Items per page:

1 - 2 of 2

Similar Datasets

Estrogen Receptor ChIP-seq analysis of MCF7 cells treated with abemaciclib

Project description:We measured changes in ER binding after treatment of MCF7 cells with abemaciclib

2020-09-01 | GSE157211 | GEO

Fra2 ChIP-seq analysis of MCF7 cells treated with abemaciclib

Project description:We measured changes in AP-1 binding after treatment of MCF7 cells with abemaciclib

2020-09-01 | GSE157216 | GEO

JunB ChIP-seq analysis of MCF7 cells treated with abemaciclib

Project description:We measured changes in AP-1 factors binding after treatment of MCF7 cells with abemaciclib

2020-09-01 | GSE157218 | GEO

c-Jun ChIP-seq analysis of MCF7 cells treated with abemaciclib

Project description:We measured changes in AP-1 factors binding after treatment of MCF7 cells with abemaciclib

2020-09-03 | GSE157385 | GEO

RNA-seq analysis of MCF7 cells treated with abemaciclib, SR11302

Project description:We measured changes in gene expression in MCF7 with CDK4/6 and AP-1 inhibition by abemaciclib and SR11302, respectively.

2020-09-01 | GSE157214 | GEO

Chromatin enrichment of TRIM24, estrogen receptor and H3K4me2 in estrogen-treated and -untreated MCF7 cells

Project description:TRIM24 PHD-Bromo domains exhibit preferential binding to unmethylated H3K4 and acetylated H3K27. TRIM24 is a co-activator of estrogen receptor (ER). The results suggest that specific ER-binding sites are depleted of H3K4me2 with estrogen treatment. TRIM24 binds these sites preferentially and facilitates ER-regulated gene expression, cell survival and proliferation. ChIP performed on MCF7 cells +/- estrogen with antibodies against ER, TRIM24 and H3K4me2. ChIP assays of ER, co-activator TRIM24 and H3K4me2 were performed with two concentrations of antibody, without and 6h with estrogen treatment of MCF7 cells. Antibody-enriched samples were sequenced two times, and compared to an IgG negative control and Input. Enriched DNA sequenced by Illumina Solexa.

2010-09-17 | E-GEOD-24166 | biostudies-arrayexpress

Bulk and single cell RNA-seq of MCF7 and MCF7 TDP2-KO cells treated with/without estrogen

Project description:To investigate the function of tyrosyl-DNA phosphodiesterase 2 (TDP2) in estrogen receptor (ER) positive breast cancer, we perfomed bulk and single-cell RNA-seq on MCF7 and MCF7 TDP2-KO cells treated with/without estrogen .

2024-04-17 | GSE225423 | GEO

Transcriptional effect of CRH on MCF7 estrogen receptor signalling

Project description:MCF7 cells were stimulated with vehicle or 100nM corticotropin releasing hormone (CRH) for 24h. The effect of CRH on the expression of genes relevant to estrogen signalling was investigated by using the Human Estrogen Receptor Signaling RT² Profiler™ PCR Array (SABioscience Corp).

2013-07-02 | GSE47958 | GEO

ChIP-seq analysis of MCF7 cells treated with abemaciclib [ER]

Project description:ChIP-seq analysis of MCF7 cells treated with abemaciclib [ER]

| PRJNA548955 | ENA

Fra2 ChIP-seq analysis of MCF7 cells treated with abemaciclib

Project description:Fra2 ChIP-seq analysis of MCF7 cells treated with abemaciclib

| PRJNA660455 | ENA